How can we help?
Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL

Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL near me in Cuttack

Also referred as
comprehensive analysis of genetic alterations of MPNs
For men & women
Earliest reports in
384 hours
Contains
1 test
Know more about this test

The Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL utilizes a combination of Next-Generation Sequencing (NGS) and Reverse Transcription Polymerase Chain Reaction (RT-PCR) techniques for the comprehensive analysis of genetic alterations (mutations) associated with MPNs, with a specific focus on the BCR-ABL fusion gene. MPNs are clonal stem cell disorders characterized by increased proliferation of one or more hematopoietic blood cell lineages. This panel combines NGS technology to identify various genetic mutations and gene rearrangements associated with MPNs, along with RT-PCR to specifically detect the presence of the BCR-ABL fusion gene. This comprehensive approach enables accurate and efficient diagnosis, monitoring, and personalized treatment planning for patients with MPNs, particularly those with BCR-ABL-positive disease. This panel is widely available with Tata 1mg labs at an affordable price in Cuttack. 

Samples required
Blood
Find out
Why is this test booked?
Preparation for this test
Sample Collection
Who will collect your samples?

Understanding Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL

Chronic myeloproliferative neoplasms (MPNs) are a group of blood disorders where the bone marrow produces too many red blood cells, white blood cells, or platelets. This uncontrolled cell growth can lead to complications such as blood clots, bleeding problems, or progression to acute leukemia.

The Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL combines next-generation sequencing (NGS) with reflex testing to identify mutations in the BCR-ABL1, JAK2, MPL, and CALR genes. All of these genes play a vital role in the diagnosis and classification of MPNs.

This test works in a stepwise or “reflex” manner. It first screens for the BCR-ABL1 fusion gene, the hallmark of chronic myeloid leukemia (CML). If BCR-ABL1 is negative, the test reflexively analyzes other MPN-related genes known as JAK2 (including the common V617F and exon 12–15 mutations), followed by MPL and CALR if needed.

By examining these genetic regions sequentially, the test distinguishes CML (BCR-ABL–positive) from BCR-ABL–negative MPNs, such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). This comprehensive approach ensures an accurate molecular diagnosis, supports personalized treatment planning, and helps doctors monitor disease progression and treatment response effectively.

Doctors may recommend this panel if you experience symptoms such as fatigue, weakness, night sweats, or an enlarged spleen, or if you have abnormal blood counts. It is also advised for individuals with a family history of MPNs or known genetic risk factors. This test helps diagnose specific MPNs, differentiate between subtypes for appropriate treatment, monitor therapy response, and assess complication risks.

For this test, it is important to submit the clinical history, histopathology report, previous test results, and a doctor’s prescription at the time of sample collection. The Tata 1mg consolidated Test Requisition Form (TRF) must also be duly filled and submitted.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results.

Note: Genetic counseling can be provided. If interested, please send the request to this email id: [email protected]

See more

What does Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL measure?

The Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL measures specific genetic mutations that drive abnormal blood cell production. It detects the BCR-ABL1 fusion gene, which confirms chronic myeloid leukemia (CML), and reflexively analyzes JAK2, CALR, and MPL mutations to identify BCR-ABL–negative MPNs such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).

By combining these analyses, the test provides a complete molecular picture of the disease, helping doctors confirm the exact MPN subtype, predict disease behavior, and plan safe and effective treatment strategies. Abnormal results indicate the presence of genetic mutations responsible for uncontrolled blood cell production, guiding doctors in making precise and personalized therapeutic decisions.

Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL test price for other cities

Price inBangaloreRs. 11780
Price inHyderabadRs. 11780
Price inAllahabadRs. 11780
Price inAsansolRs. 11780
Price inBhopalRs. 11780

How does home sample collection work?

Download the Tata 1mg app. Trusted healthcare, at your fingertips.

Book tests, track reports, and get AI-powered health insights.

or

Other tests

Test conducted by
MedGenome Labs Limited
ISO, CAP, NABL certified
Know More
Contains 1 test
Myeloproliferative Neoplasm (MPN) Reflex Panel With BCR-ABL